[Lymphatic tuberculosis with an atypical presentation in a patient with myelodysplastic syndrome: an unusual association].
Arenas
M
M
Tovar
A
A
Martínez
V
V
Calduch
J V
JV
del Mar Segarra
M
M
Mata
B
B
D000368:Aged; D000369:Aged, 80 and over; D000753:Anemia, Refractory / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D000756:Anemia, Sideroblastic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007538:Isoniazid / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014388:Tuberculosis, Lymph Node / Q000150:complications* / Q000188:drug therapy; D014803:Vitamin B Complex / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D014803:Vitamin B Complex; D004977:Ethambutol; D005492:Folic Acid; D013974:Thyroxine; D007538:Isoniazid; D012293:Rifampin